Integrated analysis identifies CCNA2 as a candidate diagnostic and prognostic biomarker in oral tongue squamous cell carcinoma
DOI:
https://doi.org/10.1590/1678-7765-2025-0618Keywords:
Squamous cell carcinoma of head and neck, Biomarkers, Prognosis, Gene expression, CCNA2 protein, humanAbstract
Background Oral tongue squamous cell carcinoma (OTSCC) is an aggressive malignancy with poor prognosis, necessitating reliable biomarkers. Methodology Genes with significantly higher expression in OTSCC tumor tissues compared to normal tongue tissues were identified via integrated transcriptomic analysis of seven GEO datasets. To assess their diagnostic and prognostic potential, these genes were further characterized using multi-omic and clinical data from the TCGA-OTSCC and CPTAC-OTSCC cohorts. Results A total of 1,117 genes were found to be upregulated in OTSCC tissues, among which only CCNA2 (Cyclin A2) was significantly associated with both reduced overall survival (OS) and disease-free survival (DFS) in the TCGA-OTSCC cohort (n=128), based on Cox proportional hazards regression and Kaplan–Meier analyses. CCNA2 showed moderate prognostic performance (AUC=0.63 for OS; AUC=0.65 for DFS) and was significantly upregulated in higher-grade tumors (p=0.01) and in deceased patients (p=0.03). No somatic mutations or promoter methylation alterations were observed in CCNA2 based on TCGA data. In CPTAC-OTSCC samples (n=18), CCNA2 protein expression was significantly higher in tumor tissues than in non-tumoral tissues (p <0.0001), with a positive correlation between mRNA and protein levels (r=0.56, p=0.01). Both mRNA and protein forms showed strong diagnostic performance (AUC=0.92 and AUC=0.82, respectively), consistent with observations across multiple tumor types. While CCNA2 protein levels showed prognostic relevance for OS (AUC=0.69, p=0.01), the mRNA-based prediction did not reach statistical significance (AUC=0.63, p=0.36). Functional enrichment analysis of CCNA2 co-expressed genes predicted involvement in cell cycle, mismatch repair, and DNA replication pathways. Additionally, protein–protein interaction analysis positioned CCNA2 as a central hub, suggesting its potential role in OTSCC pathogenesis. Conclusions These findings indicate that CCNA2 is a promising diagnostic and prognostic biomarker candidate in OTSCC. Given the small size of the CPTAC validation cohort, further studies in larger, independent OTSCC cohorts are warranted to confirm its clinical utility.
Downloads
References
1- Johnson NW, Jayasekara P, Amarasinghe AA. Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol 2000. 2011;57(1):19-37. doi: 10.1111/j.1600-0757.2011.00401.x.
» https://doi.org/10.1111/j.1600-0757.2011.00401.x
2- Davaatsend O, Altannamar M, Batbayar B, Jagdagsuren U. Factors influencing the 5-year survival rate of oral cancer patients in the Mongolian population: a retrospective cohort study. Front Oral Health. 2023;4:1292720. doi: 10.3389/froh.2023.1292720
» https://doi.org/10.3389/froh.2023.1292720
3- Tang M, Dai W, Wu H, Xu X, Jiang B, Wei Y, et al. Transcriptome analysis of tongue cancer based on high-throughput sequencing. Oncol Rep. 2020;43(6):2004-16. doi: 10.3892/or.2020.7560
» https://doi.org/10.3892/or.2020.7560
4- Thangaraj SV, Shyamsundar V, Krishnamurthy A, Ramani P, Ganesan K, Muthuswami M, et al. Molecular portrait of oral tongue squamous cell carcinoma shown by integrative meta-analysis of expression profiles with validations. PloS One. 2016;11(6):e0156582. doi: 10.1371/journal.pone.0156582
» https://doi.org/10.1371/journal.pone.0156582
5- Yang M, Zeng C, Gong Z, Shao B, Liu G, Bao X, et al. Development and validation of a predictive model for immune-related genes in patients with tongue squamous cell carcinoma. Open Life Sci. 2022;17(1):1657-68. doi: 10.1515/biol-2022-0469
» https://doi.org/10.1515/biol-2022-0469
6- Sun J, Guo F, Tang Q, Chen G, Peng J, Shen Y, et al. Identification of a novel immune gene panel in tongue squamous cell carcinoma. Am J Transl Res. 2022;14(5):2801-24.
7- Liang L, Li Y, Ying B, Huang X, Liao S, Yang J, et al. Mutation-associated transcripts reconstruct the prognostic features of oral tongue squamous cell carcinoma. Int J Oral Sci. 2023;15(1):1. doi: 10.1038/s41368-022-00210-3
» https://doi.org/10.1038/s41368-022-00210-3
8- Chen WL, Wang XK, Wu W. Identification of ITGA3 as an oncogene in human tongue cancer via integrated bioinformatics analysis. Curr Med Sci. 2018;38(4):714-20. doi: 10.1007/s11596-018-1935-9
» https://doi.org/10.1007/s11596-018-1935-9
9- Dou H, Song C, Wang X, Feng Z, Su Y, Wang H. Integrated bioinformatics analysis of SEMA3C in tongue squamous cell carcinoma using machine-learning strategies. Cancer Cell Int. 2024;24(1):58. doi: 10.1186/s12935-024-03247-y
» https://doi.org/10.1186/s12935-024-03247-y
10- Enokida T, Fujii S, Takahashi M, Higuchi Y, Nomura S, Wakasugi T, et al. Gene expression profiling to predict recurrence of advanced squamous cell carcinoma of the tongue: discovery and external validation. Oncotarget. 2017;8(37):61786-99. doi: 10.18632/oncotarget.18692
» https://doi.org/10.18632/oncotarget.18692
11- Fang W, Chen S, Wan D, Peng Y, Yang X. Identification and Validation of an Invasion-related disease-free survival prognostic model for tongue squamous cell carcinoma. Oncology. 2025;103(3):237-52. doi: 10.1159/000540977
» https://doi.org/10.1159/000540977
12- Qiu Z, Sun W, Gao S, Zhou H, Tan W, Cao M, et al. A 16-gene signature predicting prognosis of patients with oral tongue squamous cell carcinoma. PeerJ. 2017;5:e4062. doi: 10.7717/peerj.4062
» https://doi.org/10.7717/peerj.4062
13- Almangush A, Heikkinen I, Mäkitie AA, Coletta RD, Läärä E, Leivo I, et al. Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis. Brit J Cancer. 2017;117(6):856-66. doi: 10.1038/bjc.2017.244
» https://doi.org/10.1038/bjc.2017.244
14- Huang C, Chen L, Savage SR, Eguez RV, Dou Y, Li Y, et al. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell. 2021;39(3):361-79.e16. doi: 10.1016/j.ccell.2020.12.007
» https://doi.org/10.1016/j.ccell.2020.12.007
15- Evans JD. Straightforward statistics for the behavioral sciences: Thomson Brooks/Cole Publishing Co; 1996.
16- Lambert R, Sauvaget C, Camargo Cancela M, Sankaranarayanan R. Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol. 2011;23(8):633-41. doi: 10.1097/MEG.0b013e3283484795
» https://doi.org/10.1097/MEG.0b013e3283484795
17- Tranby EP, Heaton LJ, Tomar SL, Kelly AL, Fager GL, Backley M, et al. Oral cancer prevalence, mortality, and costs in medicaid and commercial insurance claims data. Cancer Epidemiol Biomarkers Prev. 2022;31(9):1849-57. doi: 10.1158/1055-9965.Epi-22-0114
» https://doi.org/10.1158/1055-9965.Epi-22-0114
18- Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global cancer observatory: cancer today (internet). Lyon (France): International Agency for Research on Cancer; 2024. Available from: https://gco.iarc.who.int/today
» https://gco.iarc.who.int/today
19- Weatherspoon DJ, Chattopadhyay A, Boroumand S, Garcia I. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010. Cancer Epidemiol. 2015;39(4):497-504. doi: 10.1016/j.canep.2015.04.007
» https://doi.org/10.1016/j.canep.2015.04.007
20- Conway DI, Purkayastha M, Chestnutt IG. The changing epidemiology of oral cancer: definitions, trends, and risk factors. Br Dent J. 2018;225(9):867-73. doi: 10.1038/sj.bdj.2018.922
» https://doi.org/10.1038/sj.bdj.2018.922
21- Taberna M, Mena M, Pavón MA, Alemany L, Gillison ML, Mesía R. Human papillomavirus-related oropharyngeal cancer. Ann Oncol. 2017;28(10):2386-98. doi: 10.1093/annonc/mdx304
» https://doi.org/10.1093/annonc/mdx304
22- Ramadan S, Mokhtari TE, Al-Qurayshi Z, Rich JT, Harbison RA, Zolkind P, et al. Trends in incidence of oral cavity squamous cell carcinoma in the United States 2001-2019. Surgical Oncology Insight. 2024;1(2). doi: 10.1016/j.soi.2024.100055
» https://doi.org/10.1016/j.soi.2024.100055
23- Severino P, Alvares AM, Michaluart P Jr, Okamoto OK, Nunes FD, Moreira-Filho CA, et al. Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites. BMC Res Notes. 2008;1:113. doi: 10.1186/1756-0500-1-113
» https://doi.org/10.1186/1756-0500-1-113
24- Al-Rawi NH, Hachim IY, Hachim MY, Salmeh A, Uthman AT, Marei H. Anatomical landscape of oral squamous cell carcinoma: A single cancer center study in UAE. Heliyon. 2023;9(5):e15884. doi: 10.1016/j.heliyon.2023.e15884
» https://doi.org/10.1016/j.heliyon.2023.e15884
25- Rivera-Peña B, Folawiyo O, Turaga N, Rodríguez-Benítez RJ, Felici ME, Aponte-Ortiz JA, et al. Promoter DNA methylation patterns in oral, laryngeal and oropharyngeal anatomical regions are associated with tumor differentiation, nodal involvement and survival. Oncol Lett. 2024;27(3):89. doi: 10.3892/ol.2024.14223
» https://doi.org/10.3892/ol.2024.14223
26- Trotta BM, Pease CS, Rasamny JJ, Raghavan P, Mukherjee S. Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning. Radiographics. 2011;31(2):339-54. doi: 10.1148/rg.312105107
» https://doi.org/10.1148/rg.312105107
27- Zelefsky MJ, Harrison LB, Fass DE, Armstrong J, Spiro RH, Shah JP, et al. Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome. Head Neck. 1990;12(6):470-5. doi: 10.1002/hed.2880120604
» https://doi.org/10.1002/hed.2880120604
28- Lin NC, Hsien SI, Hsu JT, Chen MY. Impact on patients with oral squamous cell carcinoma in different anatomical subsites: a single-center study in Taiwan. Sci Rep. 2021;11(1):15446. doi: 10.1038/s41598-021-95007-5
» https://doi.org/10.1038/s41598-021-95007-5
29- Harada H, Kikuchi M, Asato R, Hamaguchi K, Tamaki H, Mizuta M, et al. Characteristics of oral squamous cell carcinoma focusing on cases unaffected by smoking and drinking: a multicenter retrospective study. Head Neck. 2023;45(7):1812-22. doi: 10.1002/hed.27398
» https://doi.org/10.1002/hed.27398
30- Stepan KO, Mazul AL, Larson J, Shah P, Jackson RS, Pipkorn P, et al. Changing epidemiology of oral cavity cancer in the United States. Otolaryngol Head Neck Surg. 2023;168(4):761-8. doi: 10.1177/01945998221098011
» https://doi.org/10.1177/01945998221098011
31- Farhood Z, Simpson M, Ward GM, Walker RJ, Osazuwa-Peters N. Does anatomic subsite influence oral cavity cancer mortality? A SEER database analysis. 2019;129(6):1400-6. doi: 10.1002/lary.27490
» https://doi.org/10.1002/lary.27490
32- Montero PH, Yu C, Palmer FL, Patel PD, Ganly I, Shah JP, et al. Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. 2014;120(2):214-21. doi: 10.1002/cncr.28407
» https://doi.org/10.1002/cncr.28407
33- Su WW, Su CW, Chang DC, Chuang SL, Chen SL, Hsu CY, et al. Impact of varying anatomic sites on advanced stage and survival of oral cancer: 9-year prospective cohort of 27 717 cases. 2019;41(5):1475-83. doi: 10.1002/hed.25579
» https://doi.org/10.1002/hed.25579
34- Justesen MM, Stampe H, Jakobsen KK, Andersen AO, Jensen JM, Nielsen KJ, et al. Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: a retrospective cohort study from 2000 to 2019. Oral Oncol. 2024;149:106684. doi: 10.1016/j.oraloncology.2024.106684
» https://doi.org/10.1016/j.oraloncology.2024.106684
35- Liao CT, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, et al. Tongue and buccal mucosa carcinoma: is there a difference in outcome? Ann Surg Oncol. 2010;17(11):2984-91. doi: 10.1245/s10434-010-1174-1
» https://doi.org/10.1245/s10434-010-1174-1
36- Dong L, Xue L, Cheng W, Tang J, Ran J, Li Y. Comprehensive survival analysis of oral squamous cell carcinoma patients undergoing initial radical surgery. BMC Oral Health. 2024;24(1):919. doi: 10.1186/s12903-024-04690-z
» https://doi.org/10.1186/s12903-024-04690-z
37- Kim YJ, Kim JH. Increasing incidence and improving survival of oral tongue squamous cell carcinoma. Sci Rep. 2020;10(1):7877. doi: 10.1038/s41598-020-64748-0
» https://doi.org/10.1038/s41598-020-64748-0
38- Li R, Koch WM, Fakhry C, Gourin CG. Distinct epidemiologic characteristics of oral tongue cancer patients. Otolaryngol Head Neck Surg. 2013;148(5):792-6. doi: 10.1177/0194599813477992
» https://doi.org/10.1177/0194599813477992
39- Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncology. 2010;46(9):630-5. doi: 10.1016/j.oraloncology.2010.06.006
» https://doi.org/10.1016/j.oraloncology.2010.06.006
40- Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, et al. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral oncology. 2018;76:8-15. doi: 10.1016/j.oraloncology.2017.11.015
» https://doi.org/10.1016/j.oraloncology.2017.11.015
41- Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma--an update. CA Cancer J Clin.2015;65(5):401-21. doi: 10.3322/caac.21293
» https://doi.org/10.3322/caac.21293
42- Prince S, Bailey BM. Squamous carcinoma of the tongue: review. Br J Oral Maxillofac Surg. 1999;37(3):164-74. doi: 10.1054/bjom.1999.0031
» https://doi.org/10.1054/bjom.1999.0031
43- Rusthoven K, Ballonoff A, Raben D, Chen C. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer. 2008;112(2):345-51. doi: 10.1002/cncr.23183
» https://doi.org/10.1002/cncr.23183
44- Nair S, Singh B, Pawar PV, Datta S, Nair D, Kane S, et al. Squamous cell carcinoma of tongue and buccal mucosa: clinico-pathologically different entities. Eur Arch Otorhinolaryngol. 2016;273(11):3921-8. doi: 10.1007/s00405-016-4051-0
» https://doi.org/10.1007/s00405-016-4051-0
45- Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II). Oral Oncol. 2010;46(9):636-43. doi: 10.1016/j.oraloncology.2010.06.008
» https://doi.org/10.1016/j.oraloncology.2010.06.008
46- Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. doi: 10.3322/caac.21820
» https://doi.org/10.3322/caac.21820
47- Yue K, Yao X. Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma. BMC Oral Health. 2023;23(1):484. doi: 10.1186/s12903-023-03157-x
» https://doi.org/10.1186/s12903-023-03157-x
48- Zhang J, Di Y, Zhang B, Li T, Li D, Zhang H. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma. Medicine. 2024;103(16):e37831. doi: 10.1097/md.0000000000037831
» https://doi.org/10.1097/md.0000000000037831
49- Kumari P, Kumar S, Sethy M, Bhue S, Mohanta BK, Dixit A. Identification of therapeutically potential targets and their ligands for the treatment of OSCC. Front Oncol. 2022;12:910494. doi: 10.3389/fonc.2022.910494
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Todo o conteúdo do periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons do tipo atribuição CC-BY.
